Our Markets

NEONATAL COMPLICATIONS

1.3 MILLION CASES PER YEAR

• About one third of all new born infant deaths are related to respiratory complications.

• Nitric Oxide is currently being used to cure these problems in infants, with a high degree of success.

• Treatments cost about $125 per hour and usually last about 72 hours.

• Due to the high cost, the use of Nitric Oxide in this market is very limited.

• Nu-Med Plus is developing a cost-effective way to produce and transmit Nitric Oxide.

COPD

80 MILLION CASES PER YEAR

• A disease of the lungs that is the third leading cause of death in the U.S. and the fourth leading cause of death worldwide.

TUBERCULOSIS

8 MILLION CASES PER YEAR

• Lethal infectious disease that attacks the lungs of the person infected.
• Nitric Oxide has been used in trials and has shown promising results to cure the disease.

ARDS

2.2 MILLION CASES PER YEAR

• Severe lung syndrome with no known cure.
• Inhaled Nitric Oxide reduces the vascular resistance of open alveoli, exerting a potentially beneficial effect on arterial oxygenation.

MALARIA

216 MILLION CASES PER YEAR

• This disease is transmitted through mosquitoes to humans and is most prevalent in Africa.
• About 1 million people die every year from this disease and there is currently no known cure.
• Most of the survivors have severe respiratory problems.
• Inhaled NO potentially may well be used as adjuvant therapy in children with severe malaria because of its’ systemic anti-inflammatory properties to “buy time” for chemical antiparasite therapy to lower the parasite load.